Patient Views on Managing Fatty Liver Disease Through a Care Programme
Explores patients' expectations and needs before and after a liver disease care programme.
Plain-language title generated from the registry record
Registry title: Patients' Perspectives on Metabolic Dysfunction-associated Steatohepatitis: a Qualitative Study
Key facts
- Where
- Barcelona, SpainSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT07188220, who can take part
Where in Spain
- IR Sant PauBarcelona, SpainTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Trial code
- NCT07188220
- Record updated
- 23 September 2025
- Original description
The aim of this qualitative study is to explore and identify the expectations, perceptions, attitudes, needs, and knowledge related to the management of metabolic dysfunction-associated steatohepatitis (MASH) in patients diagnosed with this condition, before and after their participation in the MASH-Cardiovascular Programme at Hospital de la Santa Creu i Sant Pau, Barcelona.Read full original descriptionShow less
Perspectives on the Multidisciplinary Approach to Metabolic Dysfunction-associated Steatohepatitis: a Qualitative Study With Patients From the MASH-Cardiovascular Programme at Hospital de Sant Pau i la Santa Creu, Barcelona
The aim of this qualitative study is to explore and identify the expectations, perceptions, attitudes, needs, and knowledge related to the management of metabolic dysfunction-associated steatohepatitis (MASH) in patients diagnosed with this condition, before and after their participation in the MASH-Cardiovascular Programme at Hospital de la Santa Creu i Sant Pau, Barcelona.
The main research question is:
What expectations, attitudes, needs, and perceptions do patients with MASH participating in the MASH-Cardiovascular Programme exhibit before and after the intervention?
Participants will undergo two semi-structured interviews: one prior to, and one following, their involvement in the MASH-Cardiovascular Programme at Hospital de Sant Pau i la Santa Creu, Barcelona.
Inclusion: Patients who voluntarily agree to participate in the MASH-Cardiovascular Programme; Patients followed in the outpatient hepatology/gastroenterology clinic at Hospital de Sant Pau with a diagnosis of MASH and fibrosis stage F2-F4; Patients aged between 18 and 75 years; Patients with a BMI ≥ 27 kg/m²; Patients who consent to participate in the study-specific interviews.
Exclusion: Patients who are candidates for bariatric surgery; Patients with type 1 diabetes or other forms of diabetes; Patients with active malignancy; Patients with advanced or unstable heart failure; Patients with eating disorders or severe psychiatric illness; Patients with an eGFR < 30 mL/min; Patients who do not agree to participate in the study-specific interviews; Patients meeting exclusion criteria of the MASH-Cardiovascular Programme:; Patients with decompensated liver cirrhosis; Patients who are vegetarians or have dietary habits/preferences that prevent adherence to standard-of-care nutritional guidelines; Patients with moderate-to-severe alcohol consumption (>20 g/day for women and >40 g/day for men); Patients with malnutrition; Patients currently enrolled in another clinical trial; Pregnant women or women planning to become pregnant.